Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma of Lung 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Radiomics 1 Pituitary Diseases 1 Pancreatic Ductal Adenocarcinoma 1 Neuroendocrine Tumors 1 Lung Neoplasms 1 Lung Diseases 1 Liver Cirrhosis 1 Hepatitis B 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Disease Progression 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Carcinoma, Hepatocellular 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Sunitinib 17 Sorafenib 16 pazopanib 7 cabozantinib 7 Axitinib 7 Blood Specimen Collection 6 Bevacizumab 6 avelumab 5 Immunohistochemistry 5 temsirolimus 4 pembrolizumab 3 Watchful Waiting 3 Specimen Handling 3 Immunotherapy 3 Gene Expression Profiling 3 Everolimus 3 Urine Specimen Collection 2 Nephrectomy 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Flow Cytometry 2 Data Collection 2 Amplified Fragment Length Polymorphism Analysis 2 trastuzumab deruxtecan 1 lenvatinib 1 fluoroazomycin arabinoside 1 enfortumab vedotin 1 darolutamide 1 atezolizumab 1 aldesleukin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma, Renal Cell × Radiomics × Clear all

NCT03552497 2020-04-06

BIII

Maastricht University

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡